EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Clinical outcomes of transcatheter edge‐to‐edge repair in patients with functional mitral regurgitation and pulmonary hypertension

Alessandro Mandurino-Mirizzi iD, Luca Raone, Andrea Raffaele Munafò, Fabrizio Gazzoli, Marco Mussardo, Claudio Montalto, Francesco Germinal, Marco Ferlini, Italo Porto iD, Giuseppe Colonna, Jacopo Oreglia, Gabriele Crimi

European Journal of Clinical Investigation · 2026

DOI: 10.1111/eci.70130 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Alessandro Mandurino-Mirizzi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, "Vito Fazzi" Hospital, Lecce, Italy. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Hypertension, Pulmonary, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary hypertension (PH) is frequently observed in patients with functional mitral regurgitation (FMR) and heart failure with reduced ejection fraction (HFrEF) and adversely impacts prognosis. However, limited data exist on the outcomes of transcatheter edge‐to‐edge mitral valve repair (M‐TEER) in patients with PH, particularly regarding hemodynamic subtypes.

Methods

This multicenter, retrospective analysis included 144 HFrEF patients with moderate‐to‐severe or severe FMR who underwent M‐TEER across four Italian centers. Baseline hemodynamic assessment was performed using right heart catheterization (RHC) in conscious patients. Procedural outcomes and clinical follow‐up were evaluated at 1 year. The endpoints studied included death from any cause, heart failure hospitalization and a composite endpoint of both.

Results

Among the 144 patients, 84% had PH (64% combined post‐ and pre‐capillary‐PH (Cpc‐PH), 20% isolated post‐capillary‐PH (Ipc‐PH)). Procedural success was achieved in 92%, with significant improvements in New York Heart Association (NYHA) functional class ( p < .001) and echocardiographic parameters. At 1 year, the composite endpoint occurred in 30% of patients, with higher rates in PH patients compared to no PH group (34% vs. 9%, respectively, p = .039). Among PH patients, Cpc‐PH patients demonstrated the worst outcomes (for the composite endpoint at 1 year Cpc‐PH 37% vs. Ipc‐PH 24% vs. no‐PH 9%, p = .031). Multivariate analysis confirmed Cpc‐PH as a significant predictor of adverse outcomes at 1 year.

Conclusions

M‐TEER is an effective therapeutic option for patients with HFrEF and FMR, providing significant procedural success and clinical improvements. However, patients with PH, particularly those with Cpc‐PH, exhibit worse long‐term clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHypertension, PulmonaryHeart FailureHumansMaleFemaleRetrospective StudiesAgedCardiac CatheterizationTreatment OutcomeMiddle AgedStroke VolumeAged, 80 and overHemodynamicsEchocardiography

Stichwörter der Autor:innen

MitraClipfunctional mitral regurgitationheart failurepulmonary hypertensiontranscatheter mitral valve repair

Autor:innen und Institutionen

  • Division of Cardiology, "Vito Fazzi" Hospital, Lecce, Italy.
  • Department of Experimental Medicine (DiMeS), University of Salento, Lecce, Italy.
  • Division of Cardiology 1, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Interventional Cardiology, De Gasperis Cardio Center, Niguarda Hospital, Milan, Italy.
  • Division of Cardiac Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
  • Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.

ORCID-Profile: Alessandro Mandurino-Mirizzi, Italo Porto

Zitieren

APA

Mandurino-Mirizzi, A., Raone, L., Munafò, A. R., Gazzoli, F., Mussardo, M., Montalto, C., Germinal, F., Ferlini, M., Porto, I., Colonna, G., Oreglia, J., & Crimi, G. (2026). Clinical outcomes of transcatheter edge‐to‐edge repair in patients with functional mitral regurgitation and pulmonary hypertension. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70130

Vancouver

Mandurino-Mirizzi A, Raone L, Munafò AR, Gazzoli F, Mussardo M, Montalto C, et al. Clinical outcomes of transcatheter edge‐to‐edge repair in patients with functional mitral regurgitation and pulmonary hypertension. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70130

BibTeX
@article{MandurinoMirizzi2026,
  author = {Mandurino-Mirizzi, Alessandro and Raone, Luca and Munafò, Andrea Raffaele and Gazzoli, Fabrizio and Mussardo, Marco and Montalto, Claudio and Germinal, Francesco and Ferlini, Marco and Porto, Italo and Colonna, Giuseppe and Oreglia, Jacopo and Crimi, Gabriele},
  title = {Clinical outcomes of transcatheter edge‐to‐edge repair in patients with functional mitral regurgitation and pulmonary hypertension},
  journal = {European Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1111/eci.70130}
}
Kostenlos starten →